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To the Editor:
 
Evidence  in  favor  of  implementing  smoking  cessation 
measures  is  strong,  and  such  measures  are  critical  for 
improving  health  outcomes  among  smokers  and  others 
who  are  exposed  to  secondhand  smoke  (1,2).  Although 
some studies have evaluated the perception of the associa-
tion between tobacco use and tobacco-related diseases (3), 
they have not, to our knowledge, investigated risk percep-
tions among patients who are hospitalized with smoking-
related diseases. We surveyed a sample of such patients to 
evaluate their perceived risk and the potential for cessa-
tion interventions in this population.
 
We performed a cross-sectional analysis of 348 people 
who  were  smokers  or  former  smokers  and  who  were 
admitted to the University Hospital of Botucatu Medical 
School, São Paulo, Brazil, with tobacco-related diseases, 
from  August  2007  through  January  2008.  We  defined 
“tobacco-related disease” according to Brazilian Thoracic 
Society  and  World  Health  Organization  guidelines,  as 
follows: chronic obstructive pulmonary disease, intersti-
tial lung disease, cerebral stroke, ischemic heart disease, 
venous thromboembolism, gastritis, gastric or duodenal 
ulcer, premature labor, and cancer (lung, oral, larynges, 
esophagus, gastric, pancreas, colon/rectal, bladder, kid-
ney,  breast,  and  uterus)  (1,4).  Exclusion  criteria  were 
patients  who  were  in  unstable  condition  (undergoing 
mechanical or noninvasive ventilation, with an unstable 
hemodynamic  condition,  or  with  alterations  in  mental 
status) or who were unable to answer or understand the 
survey  questions.  Participants  gave  written  informed 
consent,  and  the  hospital  research  ethics  committee 
approved the study. We collected data on patient char-
acteristics,  knowledge  about  smoking-related  diseases, 
smoking history, and smoking cessation treatment pre-
scribed by health care professionals.
 
Most patients with smoking-related diseases were male 
(69%)  and  had  fewer  than  4  years  of  formal  education 
(70%). The leading causes of hospitalization were cardio-
vascular disease (48%), cancer (20%), and respiratory dis-
eases (12%). A substantial number of respondents (41%) 
were current smokers at the time of the hospitalization. 
This  prevalence  of  smoking  is  much  higher  than  that 
observed  for  the  adult  Brazilian  population  (10%-21%) 
(5). Exposure to secondhand smoke at home or work was 
reported by 85% of respondents. Patients reported that 
they had initiated smoking at a young age (mean 15 y), 
and 53% of the current smokers showed moderate-to-high 
nicotine  dependence,  according  to  the  Fagerström  score 
(6); 67% of the current smokers reported smoking the first 
cigarette within 30 minutes of waking up.
 
A  high  percentage  of  patients  (65%)  with  smoking-
related disease said they did not know about the associa-
tion between smoking and their disease. However, 92% of 
respondents said they had been questioned by a health 
professional about their smoking status. More than 80% 
of respondents reported that they had received only brief 
counseling  to  stop  smoking  during  the  course  of  their   
disease, including the present hospitalization, and only 7% 
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of the respondents had received specific smoking cessation 
treatment with counseling and medication.
 
Our findings suggest that hospitalization could be the 
ideal time to introduce guideline-based smoking cessation 
interventions including behavior counseling and pharma-
cologic treatment. These moments are windows of opportu-
nity to improve patients’ understanding of the relationship 
between smoking and their disease and to help them find 
smoking cessation treatment and follow-up after hospital 
discharge (7). Most patients (72%) were aware of smoking 
cessation methods, including those not recommended by 
the  most  recent  guidelines,  such  as  aversive  technique 
or hypnosis (2,4). However, only 31% of patients reported 
knowing  about  the  existence  of  specialized  services  for 
smoking cessation.
 
Limitations of our study include not taking into consid-
eration the perspective of health care professionals and 
not identifying factors that may predict differences in risk 
perception and behavior between patients. We also did not 
investigate patients’ reasons for not quitting when advised 
to do so. Therefore, we cannot exclude the possibility that 
the patients did not remember or did not comply with phy-
sician counseling or prescriptions.
 
Our findings of poor knowledge about the relationship 
between smoking and disease and the low rate of smoking 
cessation treatment reflect international problems (3,7). 
Training health professionals to adhere to guidelines by 
counseling their smoking patients more comprehensively, 
and  implementing  smoking  cessation  treatment  among 
smoking  patients  who  are  hospitalized  with  smoking-
related diseases, are effective tools to improve their health 
outcomes.  Although  costly,  treatments  for  improving 
smokers’ health outcomes are effective and they have been 
adopted, but the less expensive approach of smoking ces-
sation treatment has been neglected.
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